Equally important, the risks and types of life-threatening infections that come with myelosuppression were increasingly recognized, leading to the development and better use of more effective antibiotics. Starting in the 1990’s, cytokines, drugs that stimulate bone marrow to produce infection-fighting white blood cells, began to be integrated into cancer treatments, further mitigating the risk of life-threatening infectious complications of care.
对有生命危险的骨髓抑制感染类型及风险的认识越来越普遍，进而导致抗生素的研发及应用效率提高。20世纪90年代，刺激骨髓生成抗感染白细胞的细胞激素开始用于癌症治疗，进一步降低了危及生命的感染并发症的护理危险性。